Skip to content

?ffects of ghee consumption on plasma lipids in healthy adults

Comparing of the effects of olive oil and ghee consumption on plasma lipids and lipoproteins, adiponectin, and insulin in healthy adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160702028742N9
Enrollment
30
Registered
2021-01-05
Start date
2021-01-02
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy subjects.

Interventions

Intervention 1: Intervention group: Consume ghee in the diet for 4 weeks. The approximate amount of oil allowed for each person to prepare each of the two meals of lunch and dinner is determined and t

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: I. Adult male and non-menopausal female aged 20-60 year

Exclusion criteria

Exclusion criteria: I. History of type 2 diabetes I. History of coronary heart disease II. Abnormal liver function test (ALT and AST > 45 U/L ) III. Abnormal kidney function test (createnine > 1.4 mg/dL) IV. On lipid lowering medication V. Pregnancy and breast feeding VI. Female on oral contraceptive unless they have no intention to change during the study

Design outcomes

Primary

MeasureTime frame
Plasma LDL-cholesterol. Timepoint: Measurements at baseline (before the start of the intervention) and 4 weeks after the start. Method of measurement: Spectrophotometry.;Plasma apo B levels. Timepoint: Measurements at baseline (before the start of the intervention) and 4 weeks after the start. Method of measurement: Spectrophotometry.

Secondary

MeasureTime frame
Plasma TG. Timepoint: Measurements at baseline and 4 weeks after each intervention. Method of measurement: Spectrophotometry.;Plasma ALT. Timepoint: Measurements at baseline and 4 weeks after each intervention. Method of measurement: Spectrophotometry.;Plasma Insulin levels. Timepoint: Measurements at baseline and 4 weeks after each intervention. Method of measurement: ELISA.;Plasma Adiponectin levels. Timepoint: Measurements at baseline and 4 weeks after each intervention. Method of measurement: ELISA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJavand Nasrollahzadeh

Shahid Beheshti University of Medical Sciences

jnasrollahzadeh@gmail.com+98 21 2207 7424

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026